Novogen Limited Stock Australian S.E.
Equities
AU000000NRT0
Biotechnology & Medical Research
Sales 2022 | 10K 6.68K | Sales 2023 | 555 370.81 | Capitalization | 39.72M 26.54M |
---|---|---|---|---|---|
Net income 2022 | -24M -16.03M | Net income 2023 | -20M -13.36M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.92M | Net cash position 2023 | 3.44M 2.3M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Novogen Limited
1st Jan change | Capi. | |
---|---|---|
+47.33% | 54.63B | |
-6.72% | 39.92B | |
+37.07% | 38.82B | |
+13.90% | 26.86B | |
-11.17% | 26.22B | |
-21.88% | 18.78B | |
+25.96% | 12.21B | |
+0.75% | 12.16B | |
+26.72% | 11.94B |